INSL5 | Insulin-like 5 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30100/140637_B_1_8_rna_selected_60x60.jpg) | Group enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | ![](/images/4438/19508_B_9_3_rna_selected_60x60.jpg) | Group enriched |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25163/57017_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/6558/22094_B_9_1_rna_selected_60x60.jpg) | Group enriched |
NOX1 | NADPH oxidase 1 | Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35299/74796_A_5_3_rna_selected_60x60.jpg) | Group enriched |
MUC12 | Mucin 12, cell surface associated | Predicted membrane proteins
| | ![](/images/27769/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23835/151376_B_7_1_rna_selected_60x60.jpg) | Group enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/53525/ihc_cell_selected_60x60.jpg) | ![](/images/53525/135622_A_2_5_rna_selected_60x60.jpg) | Group enriched |
GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/18215/ihc_cell_selected_60x60.jpg) | ![](/images/18215/141725_B_8_1_rna_selected_60x60.jpg) | Group enriched |
PYY | Peptide YY | Predicted secreted proteins
| | | ![](/images/16734/ihc_cell_selected_60x60.jpg) | ![](/images/10973/51810_A_1_6_rna_selected_60x60.jpg) | Group enriched |
NXPE1 | Neurexophilin and PC-esterase domain family, member 1 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49133/151422_B_8_3_rna_selected_60x60.jpg) | Group enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/60282/ihc_cell_selected_60x60.jpg) | ![](/images/60282/134282_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21/18_B_7_1_rna_selected_60x60.jpg) | Group enriched |
CHST5 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43804/96382_B_8_5_rna_selected_60x60.jpg) | Group enriched |
DHRS11 | Dehydrogenase/reductase (SDR family) member 11 | | | ![](/images/41226/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/48236/113656_B_8_3_rna_selected_60x60.jpg) | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/2452/6277_B_7_7_rna_selected_60x60.jpg) | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | ![](/images/31032/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31033/72999_A_3_5_rna_selected_60x60.jpg) | Group enriched |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50920/117820_B_8_4_rna_selected_60x60.jpg) | Group enriched |
CDX1 | Caudal type homeobox 1 | Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images/55196/ihc_cell_selected_60x60.jpg) | ![](/images/55196/127987_B_9_1_rna_selected_60x60.jpg) | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
TPH1 | Tryptophan hydroxylase 1 | Enzymes FDA approved drug targets
| | ![](/images/22483/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10767/28958_B_2_1_rna_selected_60x60.jpg) | Group enriched |
TPSG1 | Tryptase gamma 1 | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60458/135089_B_5_5_rna_selected_60x60.jpg) | Group enriched |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/23614/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23616/52784_B_1_6_rna_selected_60x60.jpg) | Group enriched |
GPA33 | Glycoprotein A33 (transmembrane) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/18858/ihc_cell_selected_60x60.jpg) | ![](/images/18858/43097_B_2_6_rna_selected_60x60.jpg) | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3278/10188_B_8_5_rna_selected_60x60.jpg) | Group enriched |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/39738/85503_B_9_8_rna_selected_60x60.jpg) | Group enriched |
CEACAM7 | Carcinoembryonic antigen-related cell adhesion molecule 7 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/69621/152549_A_5_7_rna_selected_60x60.jpg) | Group enriched |
CLCA1 | Chloride channel accessory 1 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/52787/ihc_cell_selected_60x60.jpg) | ![](/images/59301/139587_B_5_1_rna_selected_60x60.jpg) | Group enriched |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | ![](/images/40454/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40454/144750_A_5_1_rna_selected_60x60.jpg) | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30179/63731_B_9_2_rna_selected_60x60.jpg) | Group enriched |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58564/130831_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21939/147487_B_6_5_rna_selected_60x60.jpg) | Group enriched |
CLCA4 | Chloride channel accessory 4 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17045/39405_B_8_2_rna_selected_60x60.jpg) | Group enriched |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28275/60871_B_9_1_rna_selected_60x60.jpg) | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3564/11400_B_8_2_rna_selected_60x60.jpg) | Group enriched |
KRT20 | Keratin 20 | Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/32/1899_B_2_7_rna_selected_60x60.jpg) | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/45163/ihc_cell_selected_60x60.jpg) | ![](/images/45163/100518_B_9_1_rna_selected_60x60.jpg) | Group enriched |
MUC2 | Mucin 2, oligomeric mucus/gel-forming | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/6197/ihc_cell_selected_60x60.jpg) | ![](/images/5317/18074_B_8_1_rna_selected_60x60.jpg) | Group enriched |
SLC26A3 | Solute carrier family 26 (anion exchanger), member 3 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36055/70818_B_1_8_rna_selected_60x60.jpg) | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/36493/78436_B_9_2_rna_selected_60x60.jpg) | Group enriched |
SPINK4 | Serine peptidase inhibitor, Kazal type 4 | Predicted secreted proteins
| | ![](/images/7286/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7286/23641_B_8_2_rna_selected_60x60.jpg) | Group enriched |
SULT1B1 | Sulfotransferase family, cytosolic, 1B, member 1 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2107/142116_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | ![](/images/2221/5839_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11041/27138_B_8_3_rna_selected_60x60.jpg) | Group enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | ![](/images/12012/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12012/28147_B_9_8_rna_selected_60x60.jpg) | Group enriched |
REG4 | Regenerating islet-derived family, member 4 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25867/57482_B_2_4_rna_selected_60x60.jpg) | Group enriched |
SATB2 | SATB homeobox 2 | Disease related genes Transcription factors
| | | | ![](/images/1042/2303_B_7_2_rna_selected_60x60.jpg) | Group enriched |
SULT1A2 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51051/113946_B_8_4_rna_selected_60x60.jpg) | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13690/31410_B_8_6_rna_selected_60x60.jpg) | Group enriched |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54684/126135_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |